USFDA has issued an import alert on the Rodopi unit in Greece operated by Pharmathen, which supplies Lanreotide injection to Cipla. Lanreotide is among Cipla’s top three products in the US market and commands a market share of around 22%.
USFDA has issued an import alert on the Rodopi unit in Greece operated by Pharmathen, which supplies Lanreotide injection to Cipla. Lanreotide is among Cipla’s top three products in the US market and commands a market share of around 22%.